ONO PHARMACEUTICAL CO.,LTD. 4528Short Interest
No institution currently reports a short position of 0.5% or more in ONO PHARMACEUTICAL CO.,LTD. (4528). The last disclosure was on 2026-09-17 (BNP Paribas Financial Markets SNC, 0.27%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
279 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 8 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-30 |
|---|---|
| Latest disclosure | 2026-09-17 (BNP Paribas Financial Markets SNC, 0.27%) |
| Reporting institutions | 11 firms (279 reports) |
| Peak estimated short interest | 3.55% (2025-03-27, 5 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- BNP Paribas Financial Markets SNC
- Integrated Core Strategies (Asia) Pte. Ltd.
- Barclays Bank PLC
- J.P. MORGAN SECURITIES PLC
- Qube Research & Technologies Limited
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-03-13 | MERRILL LYNCH INTERNATIONAL | Position 2,417,353 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
| 2025-03-07 | JPM Securities Japan Co Ltd. | Position 2,386,889 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2026-03-17 | Barclays Bank PLC | Position 2,236,683 shares | Ratio 0.44% | ▼0.25% | Below 0.5% |
| 2024-05-20 | GOLDMAN SACHS INTERNATIONAL | Position 1,940,141 shares | Ratio 0.38% | ▼0.18% | Below 0.5% |
| 2025-10-29 | Jefferies International Limited | Position 1,640,000 shares | Ratio 0.32% | ▼0.21% | Below 0.5% |
| 2026-09-17 | BNP Paribas Financial Markets SNC | Position 1,373,357 shares | Ratio 0.27% | ▼0.23% | Below 0.5% |
| 2025-04-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,111,362 shares | Ratio 0.22% | ▼0.30% | Below 0.5% |
| 2025-02-18 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 739,192 shares | Ratio 0.14% | ▼0.71% | Below 0.5% |
| 2025-08-26 | Qube Research & Technologies Limited | Position 0 shares | Ratio 0.00% | ▼0.51% | Closed |
| 2025-03-18 | Citigroup Global Markets Limited | Position 0 shares | Ratio 0.00% | ▼0.50% | Closed |
| 2026-09-15 | J.P. MORGAN SECURITIES PLC | Position 0 shares | Ratio 0.00% | ▼0.50% | Closed |
Disclosure History 279 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-09-17 | BNP Paribas Financial Markets SNC | Position 1,373,357 shares | Ratio 0.27% | ▼0.23% | Below 0.5% |
| 2026-09-16 | BNP Paribas Financial Markets SNC | Position 2,537,721 shares | Ratio 0.50% | ▲0.21% | — |
| 2026-09-15 | J.P. MORGAN SECURITIES PLC | Position 0 shares | Ratio 0.00% | ▼0.50% | Closed |
| 2026-09-14 | J.P. MORGAN SECURITIES PLC | Position 2,540,585 shares | Ratio 0.50% | ▲0.07% | — |
| 2026-04-10 | J.P. MORGAN SECURITIES PLC | Position 0 shares | Ratio 0.00% | ▼0.56% | Closed |
| 2026-04-07 | J.P. MORGAN SECURITIES PLC | Position 2,815,461 shares | Ratio 0.56% | ▲0.21% | — |
| 2026-03-30 | BNP Paribas Financial Markets SNC | Position 2,093,955 shares | Ratio 0.41% | ▼0.18% | Below 0.5% |
| 2026-03-27 | BNP Paribas Financial Markets SNC | Position 2,973,484 shares | Ratio 0.59% | ▼0.03% | — |
| 2026-03-24 | BNP Paribas Financial Markets SNC | Position 3,139,584 shares | Ratio 0.62% | ▼0.48% | — |
| 2026-03-23 | BNP Paribas Financial Markets SNC | Position 5,529,584 shares | Ratio 1.10% | ▲0.05% | — |
| 2026-03-19 | BNP Paribas Financial Markets SNC | Position 5,249,284 shares | Ratio 1.05% | ▼0.36% | — |
| 2026-03-18 | BNP Paribas Financial Markets SNC | Position 7,035,784 shares | Ratio 1.41% | ▲0.11% | — |
| 2026-03-17 | BNP Paribas Financial Markets SNC | Position 6,517,384 shares | Ratio 1.30% | ▲0.31% | — |
| 2026-03-17 | Barclays Bank PLC | Position 2,236,683 shares | Ratio 0.44% | ▼0.25% | Below 0.5% |
| 2026-03-16 | BNP Paribas Financial Markets SNC | Position 4,940,584 shares | Ratio 0.99% | ▲0.66% | — |
| 2026-03-13 | MERRILL LYNCH INTERNATIONAL | Position 2,417,353 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
| 2026-03-12 | MERRILL LYNCH INTERNATIONAL | Position 2,661,053 shares | Ratio 0.53% | ▼0.04% | — |
| 2026-03-11 | MERRILL LYNCH INTERNATIONAL | Position 2,848,102 shares | Ratio 0.57% | ▲0.10% | — |
| 2026-03-05 | Barclays Bank PLC | Position 3,458,714 shares | Ratio 0.69% | ▼0.11% | — |
| 2026-01-20 | Barclays Bank PLC | Position 4,023,766 shares | Ratio 0.80% | ▲0.01% | — |
| 2026-01-19 | Barclays Bank PLC | Position 3,987,735 shares | Ratio 0.79% | ▼0.01% | — |
| 2026-01-14 | Barclays Bank PLC | Position 3,996,335 shares | Ratio 0.80% | ▲0.01% | — |
| 2026-01-13 | Barclays Bank PLC | Position 3,987,735 shares | Ratio 0.79% | ▼0.01% | — |
| 2026-01-09 | Barclays Bank PLC | Position 3,996,435 shares | Ratio 0.80% | ▲0.01% | — |
| 2025-12-24 | Barclays Bank PLC | Position 3,969,835 shares | Ratio 0.79% | ▼0.28% | — |
| 2025-10-31 | BNP Paribas Financial Markets SNC | Position 2,291,709 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
| 2025-10-30 | BNP Paribas Financial Markets SNC | Position 2,559,209 shares | Ratio 0.51% | ▲0.51% | — |
| 2025-10-29 | Jefferies International Limited | Position 1,640,000 shares | Ratio 0.32% | ▼0.21% | Below 0.5% |
| 2025-10-23 | Jefferies International Limited | Position 2,667,800 shares | Ratio 0.53% | ▼0.25% | — |
| 2025-10-16 | J.P. MORGAN SECURITIES PLC | Position 479,717 shares | Ratio 0.09% | ▼0.82% | Below 0.5% |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |